Revenues of MicroElectroMechanical Systems (MEMS) in biotechnology accounted for nearly $1 billion in 2005, says a new report published by Bourne Research. "The Bourne Report -- Medical Device Quarterly" outlines the use of (MEMS) and nanotechnology in medicine and covers next-generation technologies, products, applications and trends.
"MEMS devices have already had a small, but profound impact on cardiology, diabetes and point-of-care diagnostics, and both MEMS and nanotechnology combined are showing signs of doing the same for a variety of drug delivery mechanisms," says Marlene Bourne, principal analyst with Bourne Research. "Implantable MEMS pressure sensors for remote patient monitoring is a reality today, as is the use of silver nanoparticle-based coatings for infection control of anesthesiology catheters, and this is only the tip of the iceberg."
For more information, visit http://www.bourneresearch.com (http://www.bourneresearch.com).